GIST Info

Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal StromalTumor ^Associated PDGFRAD842V Mutation

Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Mol Cancer Ther. 2009 Aug;8(8):2172-82. Epub 2009 Aug 11. PMID: 19671739 [PubMed - in process]

High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.

Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, von Mehren M, Testa JR, Godwin AK. Genes Chromosomes Cancer. 2009 Oct;48(10):886-96. PMID: 19585585 [PubMed - in process] Related Articles